Back to Nordea Investment Management AB Nordea Investment Management AB

KNSA

9 quarters

Position history for Nordea Investment Management ABNordea Investment Management AB's holdings in Kiniksa Pharmaceuticals International, plc

Yes. Nordea Investment Management holds 99,139 shares of KNSA (Kiniksa Pharmaceuticals International), worth $7.5M, as of its Q3 2026 13F filing. It reduced the position by 8,018 shares (-7.5%) from Q2 2026. Nordea Investment Management has held KNSA since Q3 2024, across 9 quarterly 13F filings.

Current Value

$7.5M

Current Shares

99,139

Total Value Change

+$2.8M

Total Shares Change

-87,487

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
99,139
-7.5%
$7.5M0.0%$74.61
0
2026-Q2
Increased
107,157
+0.5%
$6.8M0.0%$63.95
27
2026-Q1
Decreased
106,635
-3.7%
$5.1M0.0%$48.15
0
2025-Q4
Decreased
110,682
-15.6%
$4.5M0.0%$41.25
0
2025-Q3
Increased
131,074
+0.7%
$5M0.0%$38.83
27
2025-Q2
Increased
130,160
+1.6%
$3.6M0.0%$27.67
27
2025-Q1
Decreased
128,050
-34.3%
$2.9M0.0%$22.21
0
2024-Q4
Increased
194,883
+4.4%
$3.8M0.0%$19.78
28
2024-Q3
New
186,626
-
$4.7M0.0%$24.99
37

Other major holders of KNSA: FMR LLC, Baker Bros. Advisors LP, BlackRock, Inc.

Optional analytics helps us improve. How it’s used